These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16099525)

  • 1. Effect of porosity on the release kinetics of propafenone-loaded PEG-g-PLA nanoparticles.
    Sant S; Nadeau V; Hildgen P
    J Control Release; 2005 Oct; 107(2):203-14. PubMed ID: 16099525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticles.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2010 Mar; 388(1-2):263-73. PubMed ID: 20060450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microporous structure and drug release kinetics of polymeric nanoparticles.
    Sant S; Thommes M; Hildgen P
    Langmuir; 2008 Jan; 24(1):280-7. PubMed ID: 18052222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles.
    Essa S; Louhichi F; Raymond M; Hildgen P
    J Microencapsul; 2013; 30(3):205-17. PubMed ID: 22894166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of polymer architecture on curcumin encapsulation and release from PEGylated polymer nanoparticles: Toward a drug delivery nano-platform to the CNS.
    Rabanel JM; Faivre J; Paka GD; Ramassamy C; Hildgen P; Banquy X
    Eur J Pharm Biopharm; 2015 Oct; 96():409-20. PubMed ID: 26409200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
    Giovino C; Ayensu I; Tetteh J; Boateng JS
    Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the drug incorporation properties of PLA-PEG nanoparticles.
    Govender T; Riley T; Ehtezazi T; Garnett MC; Stolnik S; Illum L; Davis SS
    Int J Pharm; 2000 Apr; 199(1):95-110. PubMed ID: 10794931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
    Mu L; Teo MM; Ning HZ; Tan CS; Feng SS
    J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
    Sheshala R; Peh KK; Darwis Y
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
    Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
    Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
    Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
    Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The release behavior of doxorubicin hydrochloride from medicated fibers prepared by emulsion-electrospinning.
    Xu X; Chen X; Ma P; Wang X; Jing X
    Eur J Pharm Biopharm; 2008 Sep; 70(1):165-70. PubMed ID: 18472256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique.
    Park SJ; Kim SH
    J Colloid Interface Sci; 2004 Mar; 271(2):336-41. PubMed ID: 14972610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micelle-like nanoparticles of PLA-PEG-PLA triblock copolymer as chemotherapeutic carrier.
    Venkatraman SS; Jie P; Min F; Freddy BY; Leong-Huat G
    Int J Pharm; 2005 Jul; 298(1):219-32. PubMed ID: 15946811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
    Parikh T; Bommana MM; Squillante E
    Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release.
    Naraharisetti PK; Lew MD; Fu YC; Lee DJ; Wang CH
    J Control Release; 2005 Feb; 102(2):345-59. PubMed ID: 15653156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.